Amphotericin B colloidal dispersion (ABCD) vs amphotericin B (AmB) in the empiric treatment of febrile neutropenic patients.

被引：0
|
作者：
White, MH
Bowden, RA
Sandler, E
Graham, ML
Noskin, G
Wingard, JR
Goldman, M
McCabe, A
Lin, JS
Gurwith, M
Miller, CB
机构：
[1] MEM SLOAN KETTERING CANC CTR,NEW YORK,NY 10021
[2] FRED HUTCHINSON CANC RES CTR,SEATTLE,WA 98104
[3] CHILDRENS MED CTR,DALLAS,TX 75235
[4] UNIV ARIZONA,MED CTR,TUCSON,AZ 85721
[5] NW MEM HOSP,CHICAGO,IL 60611
[6] INDIANA UNIV,SCH MED,INDIANAPOLIS,IN
[7] UNIV FLORIDA,HLTH SCI CTR,GAINESVILLE,FL 32611
[8] SEQUUS PHARMACEUT INC,MENLO PK,CA
[9] JOHNS HOPKINS UNIV,BALTIMORE,MD 21218
来源：
BLOOD | 1996年 / 88卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1196 / 1196
页数：1
相关论文
共 50 条
  • [1] Liposomal amphotericin B versus conventional amphotericin B in the empirical treatment of persistently febrile neutropenic patients
    Cagnoni, PJ
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 49 : 81 - 86
  • [2] Improved safety and efficacy of AmBisome (liposomal amphotericin B, L-AmB) vs. amphotericin B (CAB) in the empirical treatment of febrile neutropenic patients undergoing BMT.
    Cagnoni, PJ
    Grethlein, S
    Korones, DN
    Goldman, M
    Kaizer, H
    BONE MARROW TRANSPLANTATION, 1999, 23 : S112 - S112
  • [3] Amphotericin B colloidal dispersion vs. amphotericin B as therapy for invasive aspergillosis
    White, MH
    Anaissie, EJ
    Kusne, S
    Wingard, JR
    Hiemenz, JW
    Cantor, A
    Gurwith, M
    DuMond, C
    Mamelok, RD
    Bowden, RA
    CLINICAL INFECTIOUS DISEASES, 1997, 24 (04) : 635 - 642
  • [4] Prase III randomized trial of nyotran (liposomal, nystatin) or amphotericin B for the empiric antifungal therapy in febrile neutropenic patients.
    Powles, R
    Kulkarni, S
    Treleaven, J
    Hobbs, K
    Sirohi, B
    Bhagwati, N
    Mehta, J
    Singhal, S
    Williams, T
    BLOOD, 1999, 94 (10) : 342A - 342A
  • [5] Pharmacoeconomic analysis of liposomal amphotericin B versus conventional amphotericin B in the empirical treatment of persistently febrile neutropenic patients
    Cagnoni, PJ
    Walsh, TJ
    Prendergast, MM
    Bodensteiner, D
    Hiemenz, S
    Greenberg, RN
    Arndt, CAS
    Schuster, M
    Seibel, N
    Yeldandi, V
    Tong, KB
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (12) : 2476 - 2483
  • [6] Amphotericin B colloidal dispersion versus amphotericin B in the empirical treatment of fever and neutropenia
    Roland, WE
    CLINICAL INFECTIOUS DISEASES, 1999, 28 (04) : 935 - 935
  • [7] Amphotericin B tissue distribution in autopsy material after treatment with liposomal amphotericin B and amphotericin B colloidal dispersion
    Vogelsinger, Helene
    Weiler, Stefan
    Djanani, Angela
    Kountchev, Jordan
    Bellmann-Weiler, Rosa
    Wiedermann, Christian J.
    Bellmann, Romuald
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2006, 57 (06) : 1153 - 1160
  • [8] Amphotericin B colloidal dispersion for treatment of candidemia in immunocompromised patients
    Noskin, GA
    Pietrelli, L
    Coffey, G
    Gurwith, M
    Liang, LJ
    CLINICAL INFECTIOUS DISEASES, 1998, 26 (02) : 461 - 467
  • [9] EMPIRIC THERAPY WITH AMPHOTERICIN-B IN FEBRILE GRANULOCYTOPENIC PATIENTS
    WALSH, TJ
    LEE, J
    LECCIONES, J
    RUBIN, M
    BUTLER, K
    FRANCIS, P
    WEINBERGER, M
    ROILIDES, E
    MARSHALL, D
    GRESS, J
    PIZZO, PA
    REVIEWS OF INFECTIOUS DISEASES, 1991, 13 (03): : 496 - 503
  • [10] Efficacies of amphotericin B (AMB) lipid complex, AMB colloidal dispersion, liposomal AMB, and conventional AMB in treatment of murine coccidioidomycosis
    González, GM
    Tijerina, R
    Najvar, LK
    Bocanegra, R
    Rinaldi, MG
    Graybill, JR
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (06) : 2140 - 2143
12345